NCT02723812View on ClinicalTrials.gov

Evaluate Safety of GCFLU® Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years Old

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Influenza, Human

Interventions

BIOLOGICAL

GCFLU® Influenza vaccine (Split virion, Inactivated)

Trial Locations (1)

Unknown

Ben Luc Health centre, Bến Lức

Sponsors

Collaborators (1)

Green Cross Corporation

All Listed Sponsors

collaborator

Green Cross Corporation

INDUSTRY

lead

Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products

OTHER